Evidence map›Paper›PMID 40569748›Full record

ArticleAntimicrobial agents and chemotherapy2025

Detection of SXT/R391 integrative conjugative elements carrying tigecycline resistance genes in

Wenhui Zhang, Kai Peng, Ming Liu, Xuesong Luo, Zhiqiang Wang, Ruichao Li

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenhui Zhang *Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.ORCID 0009-0000-1135-5323
Kai Peng *Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Ming LiuCollege of Nursing and Health Management & College of Life Science and Chemistry, Wuhan Donghu College, Wuhan, China.ORCID 0000-0002-8417-1047
Xuesong LuoNational Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, China.
Zhiqiang WangJiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Ruichao LiJiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.ORCID 0000-0001-8333-9891

Funding

National Natural Science Foundation of China 32373061National Natural Science Foundation of China 32473095
6 · The paper itself

Abstract

Tigecycline is a last resort antibiotic that is used to treat serious infections; however, some bacteria have developed tigecycline resistance by producing a tigecycline-inactivating enzyme or tigecycline resistance efflux pump, encoded by

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialSeafoodShewanellaTigecyclineBacterial ProteinsMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial ProteinsTigecyclineICEsShewanellatet(X4)tigecycline resistancetmexCD2-toprJ2

Identifiers

PMID40569748
PMCPMC12326977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.